Co-Authors
This is a "connection" page, showing publications co-authored by ERIC SILBERFEIN and CARY HSU.
Connection Strength
1.054
-
Demographic and Clinicopathologic Factors of Patients With Hepatocellular Carcinoma in a Safety Net Hospital. J Surg Res. 2020 12; 256:374-380.
Score: 0.174
-
Exploring the role of quality of life in surgical decision making for patients undergoing pancreatectomy. Am J Surg. 2025 Oct; 248:116523.
Score: 0.061
-
Intraoperative fluid rate and postoperative complications for pancreatoduodenectomy. J Gastrointest Surg. 2025 Aug; 29(8):102100.
Score: 0.061
-
Pretreatment Health-Related Quality-of-Life Status and Survival in Pancreatobiliary Surgical Patients. J Am Coll Surg. 2023 04 01; 236(4):861-870.
Score: 0.052
-
Long-Term Survival and Curative-Intent Treatment in Hepatitis B or C Virus-Associated Hepatocellular Carcinoma Patients Diagnosed during Screening. Biology (Basel). 2022 Nov 01; 11(11).
Score: 0.051
-
Factors associated with inability to return to intended oncologic treatment in pancreatic cancer. Am J Surg. 2022 07; 224(1 Pt B):635-640.
Score: 0.049
-
Surgical resection of early stage hepatocellular carcinoma improves patient survival at safety net hospitals. J Surg Oncol. 2021 Mar; 123(4):963-969.
Score: 0.045
-
Survival inequity in vulnerable populations with early-stage hepatocellular carcinoma: a United States safety-net collaborative analysis. HPB (Oxford). 2021 06; 23(6):868-876.
Score: 0.045
-
Surgical management of hepatocellular carcinoma patients with portal vein thrombosis: The United States Safety Net and Academic Center Collaborative Analysis. J Surg Oncol. 2021 Feb; 123(2):407-415.
Score: 0.044
-
Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study. Ann Surg Oncol. 2021 Apr; 28(4):1929-1936.
Score: 0.044
-
Dissecting disease, race, ethnicity, and socioeconomic factors for hepatocellular carcinoma: An analysis from the United States Safety Net Collaborative. Surg Oncol. 2020 Dec; 35:120-125.
Score: 0.044
-
Impact of hepatitis C treatment on long-term outcomes for patients with hepatocellular carcinoma: a United States Safety Net Collaborative Study. HPB (Oxford). 2021 03; 23(3):422-433.
Score: 0.044
-
The Evolving Landscape of Hepatocellular Carcinoma : A US Safety Net Collaborative Analysis of Etiology of Cirrhosis. Am Surg. 2020 Jul; 86(7):865-872.
Score: 0.044
-
Long-Term Assessment of Pancreatic Function After Pancreatectomy for Cystic Neoplasms. J Surg Res. 2020 03; 247:547-555.
Score: 0.041
-
Evidence Versus Practice in Early Drain Removal After Pancreatectomy. J Surg Res. 2019 04; 236:332-339.
Score: 0.039
-
Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. Surgery. 2019 02; 165(2):307-314.
Score: 0.038
-
Sequential drain amylase to guide drain removal following pancreatectomy. HPB (Oxford). 2018 06; 20(6):514-520.
Score: 0.037
-
Evidence-Based Management of Drains Following Pancreatic Resection: A Systematic Review. Pancreas. 2018 01; 47(1):12-17.
Score: 0.036
-
A Prospective Randomized Multicenter Trial of Distal Pancreatectomy With and Without Routine Intraperitoneal Drainage. Ann Surg. 2017 09; 266(3):421-431.
Score: 0.036
-
Value of lymph node positivity in treatment planning for early stage pancreatic cancer. Surgery. 2017 09; 162(3):557-567.
Score: 0.035
-
Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection. Nutrients. 2017 Mar 07; 9(3).
Score: 0.034